MedPath
HSA Approval

UROMITEXAN INJECTION 400mg/4ml

SIN05694P

UROMITEXAN INJECTION 400mg/4ml

UROMITEXAN INJECTION 400mg/4ml

April 8, 1991

BAXTER HEALTHCARE (ASIA) PTE LTD

BAXTER HEALTHCARE (ASIA) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBAXTER HEALTHCARE (ASIA) PTE LTD
Licence HolderBAXTER HEALTHCARE (ASIA) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

V03AF01

mesna

Manufacturer Information

BAXTER HEALTHCARE (ASIA) PTE LTD

BAXTER ONCOLOGY GMBH

Active Ingredients

MESNA

100.0 mg/ml

Coenzyme M

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

UROMITEXAN INJECTION 400mg/4ml - HSA Approval | MedPath